{"id":26488,"date":"2005-05-01T21:38:00","date_gmt":"2005-05-01T19:38:00","guid":{"rendered":"https:\/\/www.embl.org\/news\/?p=26488"},"modified":"2024-11-14T16:05:07","modified_gmt":"2024-11-14T15:05:07","slug":"embls-fourth-director-general-dr-iain-mattaj-takes-office","status":"publish","type":"post","link":"https:\/\/www.embl.org\/news\/lab-matters\/embls-fourth-director-general-dr-iain-mattaj-takes-office\/","title":{"rendered":"EMBL&#8217;s fourth Director-General, Dr Iain Mattaj, takes office"},"content":{"rendered":"\n<div class=\"wp-block-image\"><figure class=\"vf-figure  | vf-figure--align vf-figure--align-inline-start   size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"175\" height=\"195\" class=\"vf-figure__image\" src=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2020\/05\/press01may05pic1s.jpg\" alt=\"\" class=\"wp-image-26490\"\/><figcaption class=\"vf-figure__caption\">Dr. Iain Mattaj<\/figcaption><\/figure><\/div>\n\n\n\n<p>Dr. Iain Mattaj today took over the leadership of the European Molecular Biology Laboratory [EMBL], a prominent basic research and training institute with laboratories in France, Germany, Italy and the UK.<\/p>\n\n\n\n<p>&#8220;The pace of progress in the life sciences is remarkable. I see my job as ensuring that EMBL matches this pace to stay at the forefront of molecular biology research,&#8221; says Dr. Mattaj.<\/p>\n\n\n\n<p>Mattaj has a unique advantage over his predecessors \u2013 he knows the laboratory very well. He has been at EMBL for over 20 years and has been highly involved in scientific planning at the lab since becoming Scientific Director in 1999.<\/p>\n\n\n\n<p>What will be the most significant challenges for the new Director-General?<\/p>\n\n\n\n<p>&#8220;One of my first challenges is to update EMBL&#8217;s facilities and modernize the infrastructure of the lab. Turning our ambitious scientific plans into reality will depend on addressing this challenge now,&#8221; he says.<\/p>\n\n\n\n<p>Mattaj&#8217;s plans include not only maintaining a leadership position in molecular biology research, but also strengthening EMBL in all areas of its missions, such as providing services, developing new instrumentation, commercializing new technologies, and training scientists at all levels.<\/p>\n\n\n\n<p>And he already has a head start on addressing these goals \u2013 last month the countries that fund EMBL voted to give the laboratory the resources needed to begin renovating the 30-year old facilities at the lab headquarters in Heidelberg. In addition, Germany, who hosts EMBL&#8217;s main laboratory, has agreed to fund a new advanced training centre. This new facility will off e r training for scientists and non-scientists [such as teachers] through courses, conferences, visits and sabbaticals.<\/p>\n\n\n\n<p>&#8220;I&#8217;m very pleased that the member states have approved this extra funding,&#8221; says Mattaj. &#8220;It&#8217;s a vote of confidence in me as well as in the directions established by my predecessor, Prof. Kafatos. It also allows me to focus on what I need to do \u2013 developing a new scientific strategy for the lab.&#8221;<\/p>\n\n\n\n<p>As for changes in EMBL&#8217;s scientific scheme, Mattaj says that the future of molecular biology lies with systems biology, which aims to understand how complete biological systems function, rather than focusing on the isolated pieces. He also knows that EMBL will need the capacity to deal with the enormous amount of data being generated by high throughput experiments in modern research.<\/p>\n\n\n\n<p>To do this, Mattaj will set up organizational structures to encourage biologists to work not only with other biologists, but also with physicists, chemists and mathematicians, in order to build a solid base for systems biology work at EMBL. The lab will also advance its capacities and services in bioinformatics to serve the wider scientific community and to give all EMBL scientists expertise in using computational methods.<\/p>\n\n\n\n<p>Dr. Mattaj will be the fourth Director General in the 31 years since EMBL was founded in 1974. His distinguished predecessors were Sir John Kendrew, Prof. Lennart Philipson, and Prof. Fotis C. Kafatos.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Iain Mattaj today took over the leadership of the European Molecular Biology Laboratory [EMBL], a prominent basic research and training institute with laboratories in France, Germany, Italy and the UK. &#8220;The pace of progress in the life sciences is remarkable. I see my job as ensuring that&hellip;<\/p>\n","protected":false},"author":16,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[17597,3],"tags":[511],"embl_taxonomy":[],"class_list":["post-26488","post","type-post","status-publish","format-standard","hentry","category-embl-announcements","category-lab-matters","tag-director-general"],"acf":{"show_featured_image":false,"vf_locked":false,"featured":false,"article_intro":"","article_sources":false,"related_links":false,"in_this_article":false,"color":"#007B53","youtube_url":"","mp4_url":"","video_caption":"","translations":false,"press_contact":"EMBL Generic"},"embl_taxonomy_terms":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>EMBL&#039;s fourth Director-General, Dr Iain Mattaj, takes office | EMBL<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.embl.org\/news\/lab-matters\/embls-fourth-director-general-dr-iain-mattaj-takes-office\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EMBL&#039;s fourth Director-General, Dr Iain Mattaj, takes office | EMBL\" \/>\n<meta property=\"og:description\" content=\"Dr. Iain Mattaj today took over the leadership of the European Molecular Biology Laboratory [EMBL], a prominent basic research and training institute with laboratories in France, Germany, Italy and the UK. &#8220;The pace of progress in the life sciences is remarkable. I see my job as ensuring that&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.embl.org\/news\/lab-matters\/embls-fourth-director-general-dr-iain-mattaj-takes-office\/\" \/>\n<meta property=\"og:site_name\" content=\"EMBL\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/embl.org\/\" \/>\n<meta property=\"article:published_time\" content=\"2005-05-01T19:38:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-14T15:05:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2020\/05\/press01may05pic1s.jpg\" \/>\n<meta name=\"author\" content=\"Guest author(s)\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@embl\" \/>\n<meta name=\"twitter:site\" content=\"@embl\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Guest author(s)\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/embls-fourth-director-general-dr-iain-mattaj-takes-office\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/embls-fourth-director-general-dr-iain-mattaj-takes-office\/\"},\"author\":{\"name\":\"Guest author(s)\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/b4d9366b2ebe691c4015c64c3619205b\"},\"headline\":\"EMBL&#8217;s fourth Director-General, Dr Iain Mattaj, takes office\",\"datePublished\":\"2005-05-01T19:38:00+00:00\",\"dateModified\":\"2024-11-14T15:05:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/embls-fourth-director-general-dr-iain-mattaj-takes-office\/\"},\"wordCount\":492,\"publisher\":{\"@id\":\"https:\/\/www.embl.org\/news\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/embls-fourth-director-general-dr-iain-mattaj-takes-office\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2020\/05\/press01may05pic1s.jpg\",\"keywords\":[\"director general\"],\"articleSection\":[\"EMBL Announcements\",\"Lab Matters\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/embls-fourth-director-general-dr-iain-mattaj-takes-office\/\",\"url\":\"https:\/\/www.embl.org\/news\/lab-matters\/embls-fourth-director-general-dr-iain-mattaj-takes-office\/\",\"name\":\"EMBL's fourth Director-General, Dr Iain Mattaj, takes office | EMBL\",\"isPartOf\":{\"@id\":\"https:\/\/www.embl.org\/news\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/embls-fourth-director-general-dr-iain-mattaj-takes-office\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/embls-fourth-director-general-dr-iain-mattaj-takes-office\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2020\/05\/press01may05pic1s.jpg\",\"datePublished\":\"2005-05-01T19:38:00+00:00\",\"dateModified\":\"2024-11-14T15:05:07+00:00\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.embl.org\/news\/lab-matters\/embls-fourth-director-general-dr-iain-mattaj-takes-office\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/embls-fourth-director-general-dr-iain-mattaj-takes-office\/#primaryimage\",\"url\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2020\/05\/press01may05pic1s.jpg\",\"contentUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2020\/05\/press01may05pic1s.jpg\",\"width\":175,\"height\":195,\"caption\":\"Dr. Iain Mattaj\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.embl.org\/news\/#website\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"name\":\"European Molecular Biology Laboratory News\",\"description\":\"News from the European Molecular Biology Laboratory\",\"publisher\":{\"@id\":\"https:\/\/www.embl.org\/news\/#organization\"},\"alternateName\":\"EMBL News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.embl.org\/news\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.embl.org\/news\/#organization\",\"name\":\"European Molecular Biology Laboratory\",\"alternateName\":\"EMBL\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"contentUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"width\":300,\"height\":144,\"caption\":\"European Molecular Biology Laboratory\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/embl.org\/\",\"https:\/\/x.com\/embl\",\"https:\/\/www.instagram.com\/embl_org\/\",\"https:\/\/www.linkedin.com\/company\/15813\/\",\"https:\/\/www.youtube.com\/user\/emblmedia\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/b4d9366b2ebe691c4015c64c3619205b\",\"name\":\"Guest author(s)\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/300b9a1d66050ae03eaeb99869c6ebb30f5184b9468e92a2b3e7d28bc9cf742d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/300b9a1d66050ae03eaeb99869c6ebb30f5184b9468e92a2b3e7d28bc9cf742d?s=96&d=mm&r=g\",\"caption\":\"Guest author(s)\"},\"description\":\"Guest author(s)\",\"url\":\"https:\/\/www.embl.org\/news\/author\/guest-author\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EMBL's fourth Director-General, Dr Iain Mattaj, takes office | EMBL","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.embl.org\/news\/lab-matters\/embls-fourth-director-general-dr-iain-mattaj-takes-office\/","og_locale":"en_US","og_type":"article","og_title":"EMBL's fourth Director-General, Dr Iain Mattaj, takes office | EMBL","og_description":"Dr. Iain Mattaj today took over the leadership of the European Molecular Biology Laboratory [EMBL], a prominent basic research and training institute with laboratories in France, Germany, Italy and the UK. &#8220;The pace of progress in the life sciences is remarkable. I see my job as ensuring that&hellip;","og_url":"https:\/\/www.embl.org\/news\/lab-matters\/embls-fourth-director-general-dr-iain-mattaj-takes-office\/","og_site_name":"EMBL","article_publisher":"https:\/\/www.facebook.com\/embl.org\/","article_published_time":"2005-05-01T19:38:00+00:00","article_modified_time":"2024-11-14T15:05:07+00:00","og_image":[{"url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2020\/05\/press01may05pic1s.jpg","type":"","width":"","height":""}],"author":"Guest author(s)","twitter_card":"summary_large_image","twitter_creator":"@embl","twitter_site":"@embl","twitter_misc":{"Written by":"Guest author(s)","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.embl.org\/news\/lab-matters\/embls-fourth-director-general-dr-iain-mattaj-takes-office\/#article","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/embls-fourth-director-general-dr-iain-mattaj-takes-office\/"},"author":{"name":"Guest author(s)","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/b4d9366b2ebe691c4015c64c3619205b"},"headline":"EMBL&#8217;s fourth Director-General, Dr Iain Mattaj, takes office","datePublished":"2005-05-01T19:38:00+00:00","dateModified":"2024-11-14T15:05:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/embls-fourth-director-general-dr-iain-mattaj-takes-office\/"},"wordCount":492,"publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"image":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/embls-fourth-director-general-dr-iain-mattaj-takes-office\/#primaryimage"},"thumbnailUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2020\/05\/press01may05pic1s.jpg","keywords":["director general"],"articleSection":["EMBL Announcements","Lab Matters"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.embl.org\/news\/lab-matters\/embls-fourth-director-general-dr-iain-mattaj-takes-office\/","url":"https:\/\/www.embl.org\/news\/lab-matters\/embls-fourth-director-general-dr-iain-mattaj-takes-office\/","name":"EMBL's fourth Director-General, Dr Iain Mattaj, takes office | EMBL","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/embls-fourth-director-general-dr-iain-mattaj-takes-office\/#primaryimage"},"image":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/embls-fourth-director-general-dr-iain-mattaj-takes-office\/#primaryimage"},"thumbnailUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2020\/05\/press01may05pic1s.jpg","datePublished":"2005-05-01T19:38:00+00:00","dateModified":"2024-11-14T15:05:07+00:00","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.embl.org\/news\/lab-matters\/embls-fourth-director-general-dr-iain-mattaj-takes-office\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/lab-matters\/embls-fourth-director-general-dr-iain-mattaj-takes-office\/#primaryimage","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2020\/05\/press01may05pic1s.jpg","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2020\/05\/press01may05pic1s.jpg","width":175,"height":195,"caption":"Dr. Iain Mattaj"},{"@type":"WebSite","@id":"https:\/\/www.embl.org\/news\/#website","url":"https:\/\/www.embl.org\/news\/","name":"European Molecular Biology Laboratory News","description":"News from the European Molecular Biology Laboratory","publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"alternateName":"EMBL News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.embl.org\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.embl.org\/news\/#organization","name":"European Molecular Biology Laboratory","alternateName":"EMBL","url":"https:\/\/www.embl.org\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","width":300,"height":144,"caption":"European Molecular Biology Laboratory"},"image":{"@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/embl.org\/","https:\/\/x.com\/embl","https:\/\/www.instagram.com\/embl_org\/","https:\/\/www.linkedin.com\/company\/15813\/","https:\/\/www.youtube.com\/user\/emblmedia\/"]},{"@type":"Person","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/b4d9366b2ebe691c4015c64c3619205b","name":"Guest author(s)","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/300b9a1d66050ae03eaeb99869c6ebb30f5184b9468e92a2b3e7d28bc9cf742d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/300b9a1d66050ae03eaeb99869c6ebb30f5184b9468e92a2b3e7d28bc9cf742d?s=96&d=mm&r=g","caption":"Guest author(s)"},"description":"Guest author(s)","url":"https:\/\/www.embl.org\/news\/author\/guest-author\/"}]}},"field_target_display":"embl","field_article_language":{"value":"english","label":"English"},"fimg_url":false,"featured_image_src":"https:\/\/www.embl.org\/news\/wp-includes\/images\/media\/default.svg","_links":{"self":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/26488","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/comments?post=26488"}],"version-history":[{"count":2,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/26488\/revisions"}],"predecessor-version":[{"id":26494,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/26488\/revisions\/26494"}],"wp:attachment":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/media?parent=26488"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/categories?post=26488"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/tags?post=26488"},{"taxonomy":"embl_taxonomy","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/embl_taxonomy?post=26488"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}